ArticleTherapeutic advances in musculoskeletal disease2022

Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis.

Riccardo Bixio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.